Publication | Closed Access

Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis

Nf-κb LigandAnti-inflammatoryBone Morphogenic ProteinMedicineNew InhibitorsReceptor ActivatorPharmacologyCell BiologyOsteocalcinDrug Discovery